Scientists have identified the protein complex that gives the hepatitis C virus the ability to bind and infect cells.

Hepatitis C vaccine development can be accelerated now that cryo-electron microscopy has revealed new details about the virus ...

Around 58 million people suffer from chronic inflammation caused by the hepatitis C virus, and 300,000 people die from the ...

Researchers conducted an observational study to compare the risk for dementia associated with both the live and recombinant shingles vaccines. The recombinant herpes zoster (shingles) vaccine is ...

Older people who avail themselves of the newest shingles vaccine could reap a hidden benefit: A significant drop in their ...

The optimal pricing strategy for a new vaccine involves setting a fair and ... ‘hangover effect’ from their approach to pricing in HCV, particularly in the US” In particular, Gilead has ...

However HIV-related immunosuppression might compromise HCV vaccine responses and effectiveness. The ideal prophylactic and therapeutic HCV vaccines for HIV-coinfected individuals therefore need to ...

Company chief commercial officer Luke Miels says GSK internal data is showing “a correlation” between those who had taken the company’s shingles vaccine, Shingrix, and a lower risk of ...

Given the global disease burden and public health impact of hepatitis C, the development of an effective vaccine is of paramount importance. However, many challenging obstacles loom ahead of this ...

Jamie Mackelfresh, MD: Currently, the CDC recommends that adults over age 50, in particular, are the core people who should think about getting the shingles vaccine. There are two different ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...